These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31672151)

  • 1. Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis.
    Bielecka-Dabrowa A; Bytyçi I; Von Haehling S; Anker S; Jozwiak J; Rysz J; Hernandez AV; Bajraktari G; Mikhailidis DP; Banach M
    Lipids Health Dis; 2019 Oct; 18(1):188. PubMed ID: 31672151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):177-88. PubMed ID: 26780905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis.
    Bonsu KO; Kadirvelu A; Reidpath DD
    Syst Rev; 2013 Apr; 2():22. PubMed ID: 23618535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Ther; 2015 Dec; 33(6):338-46. PubMed ID: 26280110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Effects of Statin Use on Mortality in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Lee MS; Duan L; Clare R; Hekimian A; Spencer H; Chen W
    Am J Cardiol; 2018 Aug; 122(3):405-412. PubMed ID: 30201108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Different Types of Statins on Clinical Outcomes in Patients Hospitalized for Ischemic Heart Failure.
    Zvizdić F; Godinjak A; Durak-Nalbantic A; Rama A; Iglica A; Vucijak-Grgurevic M; Sokolovic S
    Med Arch; 2018 Dec; 72(6):401-405. PubMed ID: 30814769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Statins on Mortality in Heart Failure With Preserved Ejection Fraction Without Coronary Artery Disease　- Report From the JASPER Study.
    Marume K; Takashio S; Nagai T; Tsujita K; Saito Y; Yoshikawa T; Anzai T
    Circ J; 2019 Jan; 83(2):357-367. PubMed ID: 30416189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.
    Tsujimoto T; Kajio H
    Int J Cardiol; 2018 Mar; 255():111-117. PubMed ID: 29307549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Lipophilicity and the Risk of Incident Heart Failure.
    Imran T; Wong A; Schneeweiss S; Desai RJ
    Cardiology; 2020; 145(6):375-383. PubMed ID: 32289796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.
    Lipinski MJ; Cauthen CA; Biondi-Zoccai GG; Abbate A; Vrtovec B; Khan BV; Vetrovec GW
    Am J Cardiol; 2009 Dec; 104(12):1708-16. PubMed ID: 19962481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins in heart failure: the paradox between large randomized clinical trials and real life.
    Gastelurrutia P; Lupón J; de Antonio M; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
    Mayo Clin Proc; 2012 Jun; 87(6):555-60. PubMed ID: 22677075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.
    Preiss D; Campbell RT; Murray HM; Ford I; Packard CJ; Sattar N; Rahimi K; Colhoun HM; Waters DD; LaRosa JC; Amarenco P; Pedersen TR; Tikkanen MJ; Koren MJ; Poulter NR; Sever PS; Ridker PM; MacFadyen JG; Solomon SD; Davis BR; Simpson LM; Nakamura H; Mizuno K; Marfisi RM; Marchioli R; Tognoni G; Athyros VG; Ray KK; Gotto AM; Clearfield MB; Downs JR; McMurray JJ
    Eur Heart J; 2015 Jun; 36(24):1536-46. PubMed ID: 25802390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.
    Liu G; Zheng XX; Xu YL; Lu J; Hui RT; Huang XH
    Heart Lung Circ; 2014 Oct; 23(10):970-7. PubMed ID: 24954758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of statin therapy to risk of heart failure after acute myocardial infarction.
    Aronson D; Mutlak D; Lessick J; Kapeliovich M; Dabbah S; Markiewicz W; Beyar R; Hammerman H; Reisner S; Agmon Y
    Am J Cardiol; 2008 Dec; 102(12):1706-10. PubMed ID: 19064028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
    Pufulete M; Maishman R; Dabner L; Higgins JPT; Rogers CA; Dayer M; MacLeod J; Purdy S; Hollingworth W; Schou M; Anguita-Sanchez M; Karlström P; Shochat MK; McDonagh T; Nightingale AK; Reeves BC
    Syst Rev; 2018 Jul; 7(1):112. PubMed ID: 30064502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials.
    Bytyçi I; Bajraktari G; Bhatt DL; Morgan CJ; Ahmed A; Aronow WS; Banach M;
    J Clin Lipidol; 2017; 11(3):624-637. PubMed ID: 28506385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ismayl M; Abbasi MA; Al-Abcha A; El-Am E; Lundgren S; Goldsweig AM; Anavekar NS
    Curr Probl Cardiol; 2023 May; 48(5):101597. PubMed ID: 36681210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.
    Al-Gobari M; Le HH; Fall M; Gueyffier F; Burnand B
    PLoS One; 2017; 12(2):e0171168. PubMed ID: 28166237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.